Health Discoveries in Pediatric Cardiology

Study focuses on body cooling for pediatrics cardiac patients

October 25, 2010
A large-scale pediatrics study involving 34 hospitals across the U.S. and Canada has begun to determine the effectiveness of body cooling treatment for infants and children who have experienced cardiac arrest.

The National Heart, Lung and Blood Institute is providing $21 million to fund the Therapeutic Hypothermia after Pediatric Cardiac Arrest (THAPCA) trials for the next six years. The cooling therapy has been used successfully for adults who have been in cardiac arrest and newborns who experience birth asphyxia (lack of oxygen).

In body cooling treatment, a patient's body temperature is controlled as he or she lies on mattress and is covered with blankets through which water is circulated. Researchers believe the treatment lessens inflammation and cell death.

Participants in the THAPCA trials must be older than 48 hours and younger than age 18 years and must be enrolled in the study within six hours of suffering cardiac arrest. with parental consent, they will be assigned to a treatment group.

U.S. News & World Report has ranked Cohen Children's Medical Center, a member of the North Shore-LIJ Health System, among the nation's top 30 children's hospitals in areas of diabetes and endocrinology, digestive disorders, respiratory disorders and urology.
  • Bookmark this Page
  • Toggle Text Size
  • Print this Page
Search Study focuses on body cooling for pediatrics cardiac patients: